Table 1 Model parameters perturbed in the global sensitivity analysis.
Parameter | Symbol | Units | Baseline [range] | Distribution | Reference |
|---|---|---|---|---|---|
Discrete (ABM) parameters | |||||
Cell cycle time*,§ | τP | hours | 20 [16.5 – 23.5] | Uniform | |
Symmetric proliferation probability | |||||
-progenitor (is daughter progenitor or differentiated?)*,†,§§ | ωP | % | 75% [50% – 100%] | Uniform | N/A |
-stem (is daughter stem?)*,†,§ | ωSC | % | 12% [12% ± 6%] | Lognormal | [46] |
-stem (are non-stem daughters ER + or ER–?)*,§§ | ωSC,+/– | % | 50% [36 – 64%] | Uniform | N/A |
Apoptosis probability*,§ | ωApop | % Δt−1 | 0.705% [0.10% – 1.31%] | Uniform | [47] |
Proliferation cycles before differentiation*,†,§§ | Pmax | Cell cycles | 18 [11 – 25] | Uniform | |
Cell density threshold for quiescence*,†,§§ | θQ | Cells volume−1 | 70% [50 – 90%] | Uniform | N/A |
Dedifferentiation probability†,§ | ΩDD | % cell−1 cycle−1 | 0.4% [0.1 – 0.7%] | Uniform | [24] |
Hybrid (ABM ↔ continuum) parameters | |||||
Cancer cell oxygen metabolism multiplier (cancer cell oxygen metabolism = λC×λE)*,†, § | λC | Mol cell-1 s−1 | 4.5× healthy cell metabolism [3.0 – 6.0×] | Uniform | [48] |
Estrogen metabolism*,§§ | λE | Normalized (% baseline) | 1.0 [0.9 – 1.1] | Uniform | N/A |
FGF uptake/metabolism*,§§ | λFGF | Normalized (% baseline) | 0.72 [0.648 – 0.792] | Uniform | N/A |
AREG production*,§§ | λAREG | Normalized (% baseline) | 0.086 [0.0774 – 0.096] | Uniform | N/A |
Estrogen proliferation threshold*,†,§§ | θE | Normalized (% baseline) | 0.85 [0.85 ± 0.2] | Lognormal | N/A |
FGF proliferation threshold*,†,§§ | θFGF | Normalized (% baseline) | 0.7 [0.7 ± 0.15] | Lognormal | N/A |